(Q37968511)

26 August 2017

Cognitive impairment in nondemented Parkinson's disease (English)

1 reference

26 August 2017

1 reference

cognitive dysfunction

1 reference

2

Dag Aarsland

1 reference

26 August 2017

1

Paolo Barone

1 reference

26 August 2017

6

Daniel Weintraub

1 reference

26 August 2017

5

Jaime Kulisevsky

1 reference

26 August 2017

David Burn

3

1 reference

PubMed ID

22170275

26 August 2017

Murat Emre

series ordinal

4

1 reference

PubMed ID

22170275

26 August 2017

language of work or name

English

0 references

publication date

24 August 2011

1 reference

26 August 2017

1 reference

26 August 2017

26

1 reference

26 August 2017

14

1 reference

26 August 2017

2483-2495

1 reference

Cognitive profile of patients with newly diagnosed Parkinson disease.

26 August 2017

1 reference

Mild cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

21 January 2018

1 reference

Risk of dementia in Parkinson's disease: a community-based, prospective study.

21 January 2018

1 reference

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.

21 January 2018

1 reference

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

21 January 2018

1 reference

Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

21 January 2018

1 reference

Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress

21 January 2018

1 reference

Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease

21 January 2018

1 reference

Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

21 January 2018

1 reference

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

21 January 2018

1 reference

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

Current concepts in mild cognitive impairment

21 January 2018

1 reference

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

21 January 2018

1 reference

Defining mild cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

Cognitive impairments in advanced PD without dementia.

21 January 2018

1 reference

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.

21 January 2018

1 reference

Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease

21 January 2018

1 reference

Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease

21 January 2018

1 reference

A meta-analysis of performance on simple span and more complex working memory tasks in Parkinson's disease

21 January 2018

1 reference

Patients with Parkinson's disease learn to control complex systems via procedural as well as non-procedural learning.

21 January 2018

1 reference

The striatum and probabilistic implicit sequence learning.

21 January 2018

1 reference

The role of the basal ganglia and its cortical connections in sequence learning: evidence from implicit and explicit sequence learning in Parkinson's disease.

21 January 2018

1 reference

Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases

21 January 2018

1 reference

Memory deficits in Parkinson's disease.

21 January 2018

1 reference

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism

21 January 2018

1 reference

Cognitive change following MPTP exposure.

21 January 2018

1 reference

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability

21 January 2018

1 reference

Visual rating of white matter hyperintensities in Parkinson's disease.

21 January 2018

1 reference

Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

21 January 2018

1 reference

Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.

21 January 2018

1 reference

Parkinson's disease is associated with hippocampal atrophy.

21 January 2018

1 reference

MRI and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry

21 January 2018

1 reference

Cerebral atrophy in Parkinson's disease patients with visual hallucinations.

21 January 2018

1 reference

A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations

21 January 2018

1 reference

Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.

21 January 2018

1 reference

The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.

21 January 2018

1 reference

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

Dopaminergic modulation of cortical function in patients with Parkinson's disease

21 January 2018

1 reference

Functional and anatomical magnetic resonance imaging in Parkinson's disease

21 January 2018

1 reference

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

Parkinson disease with dementia: comparing patients with and without Alzheimer pathology

21 January 2018

1 reference

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

21 January 2018

1 reference

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

Neuropsychological profile of patients with Parkinson's disease without dementia.

21 January 2018

1 reference

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

21 January 2018

1 reference

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

The rate of cognitive decline in Parkinson disease.

21 January 2018

1 reference

Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

21 January 2018

1 reference

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score

21 January 2018

1 reference

Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.

21 January 2018

1 reference

Course of cognitive decline in Parkinson's disease: a meta-analysis.

21 January 2018

1 reference

Memory and executive function impairment predict dementia in Parkinson's disease.

21 January 2018

1 reference

Cognitive changes in Parkinson's disease patients with visual hallucinations.

21 January 2018

1 reference

Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

21 January 2018

1 reference

Apathy may herald cognitive decline and dementia in Parkinson's disease.

21 January 2018

1 reference

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

21 January 2018

1 reference

Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease

21 January 2018

1 reference

Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia

21 January 2018

1 reference

Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients

21 January 2018

1 reference

Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.

21 January 2018

1 reference

Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.

21 January 2018

1 reference

Freezing of gait and executive functions in patients with Parkinson's disease.

21 January 2018

1 reference

Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment

21 January 2018

1 reference

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).

21 January 2018

1 reference

Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.

21 January 2018

1 reference

Population-based norms for the Mini-Mental State Examination by age and educational level

21 January 2018

1 reference

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

21 January 2018

1 reference

Evaluation of dementia rating scales in Parkinson's disease dementia.

21 January 2018

1 reference

The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.

21 January 2018

1 reference

Analysis of structure and discriminative power of the Mattis Dementia Rating Scale.

21 January 2018

1 reference

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

21 January 2018

1 reference

Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.

21 January 2018

1 reference

Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.

21 January 2018

1 reference

Assessment of cognition in Parkinson's disease.

21 January 2018

1 reference

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.

21 January 2018

1 reference

Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

21 January 2018

1 reference

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

The clinical utility of the dementia rating scale for assessing Alzheimer patients.

21 January 2018

1 reference

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

21 January 2018

1 reference

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

21 January 2018

1 reference

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia.

21 January 2018

1 reference

Association between cognition and function in patients with Parkinson disease with and without dementia

21 January 2018

1 reference

Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis

21 January 2018

1 reference

Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients

21 January 2018

1 reference

Pergolide effect on cognitive functions in early-mild Parkinson's disease

21 January 2018

1 reference

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

21 January 2018

1 reference

Levodopa and executive performance in Parkinson's disease: a randomized study.

21 January 2018

1 reference

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

21 January 2018

1 reference

Medication impairs probabilistic classification learning in Parkinson's disease.

21 January 2018

1 reference

The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease

21 January 2018

1 reference

A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease

21 January 2018

1 reference

Association between amantadine and the onset of dementia in Parkinson's disease.

21 January 2018

1 reference

Efficacy and safety of donepezil in the treatment of executive dysfunction in Parkinson disease: a pilot study

21 January 2018

1 reference

Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study.

21 January 2018

1 reference

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

21 January 2018

1 reference

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial

21 January 2018

1 reference

Benefits of physical exercise on executive functions in older people with Parkinson's disease.

21 January 2018

1 reference

Moving forward with nutrition in Alzheimer's disease

21 January 2018

1 reference

Deep brain stimulation of the subthalamic nucleus selectively improves learning of weakly associated cue combinations during probabilistic classification learning in Parkinson's disease.

21 January 2018

1 reference

Deep brain stimulation of the subthalamic nucleus improves set shifting but does not affect dual task performance in Parkinson's disease.

21 January 2018

1 reference

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

21 January 2018

1 reference

Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and after unilateral posteroventral pallidotomy.

21 January 2018

1 reference

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.

21 January 2018

1 reference

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23919

1 reference

26 August 2017

1 reference

PubMed ID

22170275